Plague | ISARIC

Performance of diagnostic procedure for bubonic plague in endemic settings in Madagascar: a prospective test accuracy sub-study with the IMASOY trial

by Asia Mace | Apr 14, 2026

Ciprofloxacin versus Aminoglycoside–Ciprofloxacin for Bubonic Plague

by Asia Mace | Apr 14, 2026

Bubonic Plague Treatment Proven Highly Effective and Safe in Global First

by Isobel Young | Aug 6, 2025 | News, Partnerships, Publications

Researchers from the UK and Madagascar, in collaboration with Madagascar’s health services and national plague programme, have conducted the world’s first rigorous clinical trial of treatments for bubonic plague. The IMASOY trial provides the first robust evidence of...

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protoco

by Wajeeha Malik | Jul 5, 2024

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial

by Wajeeha Malik | May 14, 2024

Performance of diagnostic procedure for bubonic plague in endemic settings in Madagascar: a prospective test accuracy sub-study with the IMASOY trial

Ciprofloxacin versus Aminoglycoside–Ciprofloxacin for Bubonic Plague

Bubonic Plague Treatment Proven Highly Effective and Safe in Global First

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protoco

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial

Cookies Policy